Patent · US Active

Human serum albumin-siRNA nano-sized carrier system

US8513402B2 · kind B2 · utility

1Cited by
1References
9Claims
0Family size

Assignee

Inventors

Key dates

Filing dateSep 26, 2011
Grant dateAug 20, 2013
Priority date
Expiry dateOct 12, 2031

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2320/32
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Disclosed are a human serum albumin-siRNA carrier system having siRNA bound to human serum albumin and a user thereof, and especially, human serum albumin-siRNA carrier system, which has a biodegradable covalent bond between human serum albumin polymer and siRNA and is stable in a living body, and a user thereof.The human serum albumin-siRNA carrier system having the biodegradable covalent bond between the human serum albumin and the siRNA exhibits high siRNA delivery efficiency to a target site in the living body. Therefore, the human serum albumin-siRNA carrier system may allow siRNA for therapy to be efficiently delivered to a target site such as cancer tissues in the living body even by being administrated in a relatively low concentration, which may result in a wide use for therapies of various diseases.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.